Company profile

PocDoc

Pathology & Laboratory Diagnostics

Company profile

About PocDoc

PocDoc is a UK-based health technology company revolutionising point-of-care diagnostics through smartphone-enabled blood testing. The company has developed an app-based technology platform that combines proprietary Microfluidic Assay (MFA) technology with cloud-based AI diagnostics to deliver end-to-end digital pathways for the assessment, diagnosis and treatment of Cardio, Metabolic and Renal (CMR) diseases. Their flagship product, the Healthy Heart Check, provides fully quantified lab-grade lipid panel results in under 10 minutes from a simple finger-prick blood test. The platform delivers a complete 5-marker cholesterol panel including Total Cholesterol, HDL, Non-HDL/LDL, Triglycerides, and Total Cholesterol/HDL ratio, along with Heart Age and 10-year cardiovascular disease risk calculations compared against NHS clinical guidelines. PocDoc offers solutions for both healthcare professionals (PocDoc Pro) and individual consumers, with the professional version integrating with electronic health records and clinical risk engines. The company's mission is to prevent millions of premature deaths by identifying those at highest risk of CMR diseases, addressing the critical access gap where millions of at-risk individuals have never been tested. Founded by a multidisciplinary team of scientists, entrepreneurs and healthcare professionals, PocDoc is working to make diagnostics accessible for all, particularly those at highest risk who face barriers to traditional testing.

Company description PocDoc official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at PocDoc?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardio Metabolic and Renal (CMR) diseases
  • Cardiovascular disease
  • Cholesterol disorders
  • Hyperlipidemia

Who it serves

  • Clinics
  • Health Systems
  • Healthcare Professionals
  • Individual Consumers

Deployment & integration

Cloud Saas · Embedded · Hybrid deployment with recorded integration context.

Recorded integration context: Clinical risk engines, Electronic Health Records, Insurer systems.

Geographic context

MarketsUnited Kingdom
Company sourceOfficial website

Company milestones

Platform expansion

CEO Steve Roest is member of UK Research and Innovation Future Leaders review board. Multiple Innovate UK grant awards received.

Partnerships

Recorded partners

  • Innovate UK (multiple grant awards)
  • UK Research and Innovation

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

HUESnap

Cloud-based AI diagnostic pipeline for smartphone-based colorimetric biomarker quantification

Software · Cloud SaaSCompany source

PocDoc Healthy Heart Check

At-home finger-prick cholesterol test with heart age and CVD risk in under 10 minutes

Device · HybridCompany source

PocDoc MFA (Microfluidic Assay Platform)

Patented portable quantitative digital diagnostic test platform for multi-marker analysis

Device · EmbeddedCompany source

PocDoc Pro

Point-of-care multi-marker blood testing platform for healthcare professionals

Platform · HybridCompany source

PocDocOS

Digital infrastructure platform for point-of-care testing with EHR integration and population health management

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Up to 90% of CMR disease cases could be prevented through early intervention

Citing American Heart Association research

Results in under 10 minutes

Point-of-care testing turnaround time

Lab-grade quantitative results

Clinical accuracy of 5-marker lipid panel

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Kiran Roest

Chief Strategy Officer & Co-Founder

Vladimir Gubala

Chief Scientific Officer & Co-Founder

06 · Company updates

Updates from PocDoc

Recent articles published on PocDoc's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon